Early detection and curative treatment of hepatocellular carcinoma: A cost‐effectiveness analysis in France and in the United States

Hepatocellular carcinoma (HCC) is the leading cause of death in patients with cirrhosis. Patients outside clinical trials seldom benefit from evidence‐based monitoring. The objective of this study was to estimate the cost‐effectiveness of complying with HCC screening guidelines. The economic evaluat...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Hepatology (Baltimore, Md.) Jg. 65; H. 4; S. 1237 - 1248
Hauptverfasser:	Cadier, Benjamin, Bulsei, Julie, Nahon, Pierre, Seror, Olivier, Laurent, Alexis, Rosa, Isabelle, Layese, Richard, Costentin, Charlotte, Cagnot, Carole, Durand‐Zaleski, Isabelle, Chevreul, Karine
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States Wolters Kluwer Health, Inc 01.04.2017
Schlagworte:	Aged Carcinoma, Hepatocellular - economics Carcinoma, Hepatocellular - mortality Carcinoma, Hepatocellular - pathology Carcinoma, Hepatocellular - surgery Catheter Ablation - economics Catheter Ablation - methods Catheter Ablation - mortality Cohort Studies Cost analysis Cost-Benefit Analysis - methods Databases, Factual Disease-Free Survival Early Detection of Cancer - economics Early Detection of Cancer - methods Female France Hepatectomy - economics Hepatectomy - methods Hepatectomy - mortality Hepatology Humans Liver cancer Liver Neoplasms - economics Liver Neoplasms - mortality Liver Neoplasms - pathology Liver Neoplasms - surgery Liver Transplantation - economics Liver Transplantation - methods Liver Transplantation - mortality Male Markov Chains Middle Aged Retrospective Studies Survival Analysis United States
ISSN:	0270-9139, 1527-3350, 1527-3350
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!